NEW YORK (GenomeWeb News) — Abbott today said it has extended a research partnership with Caprion Proteomics to identify and use cancer antibody targets.
 
The agreement grants Abbott exclusive rights for up to two years to 10 lung cancer targets that Caprion found.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.